$0.71
8.96% yesterday
Nasdaq, Nov 15, 10:00 pm CET
ISIN
US64130M2098
Symbol
NMTC

NeuroOne Medical Technologies Corp Target price 2024 - Analyst rating & recommendation

NeuroOne Medical Technologies Corp Classifications & Recommendation:

Hold
100%

NeuroOne Medical Technologies Corp Price Target

Target Price $2.00
Price $0.71
Potential
Number of Estimates 1
1 Analyst has issued a NeuroOne Medical Technologies Corp price target 2025. The average NeuroOne Medical Technologies Corp target price is $2.00. This is higher than the current stock price.
A rating was issued by 1 analysts: 0 Analysts recommend NeuroOne Medical Technologies Corp to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the NeuroOne Medical Technologies Corp stock has an average upside potential 2025 of . Most analysts recommend the NeuroOne Medical Technologies Corp stock at Hold.

Sales and Margin forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Sep '23 2024
Estimates
Revenue Million $ 3.41 5.50
60.85% 61.29%
EBITDA Margin -344.87% -243.64%
20.01% 29.35%
Net Margin -530.87% -191.42%
35.86% 63.94%

1 Analyst has issued a sales forecast NeuroOne Medical Technologies Corp 2024 . The average NeuroOne Medical Technologies Corp sales estimate is

$5.5m
Unlock
. This is
40.31% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$5.5m 40.31%
Unlock
, the lowest is
$5.5m 40.31%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $3.4m 60.85%
2024
$5.5m 61.29%
Unlock
2025
$10.2m 85.45%
Unlock
2026
$15.2m 49.02%
Unlock

1 Analyst has issued an EBITDA forecast NeuroOne Medical Technologies Corp 2024 . The average NeuroOne Medical Technologies Corp EBITDA estimate is

$-13.4m
Unlock
. This is
11.76% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-13.4m 11.76%
Unlock
, the lowest is
$-13.4m 11.76%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $-11.8m 28.67%
2024
$-13.4m 13.95%
Unlock
2025
$-13.5m 0.75%
Unlock
2026
$-9.3m 31.11%
Unlock

EBITDA Margin

2023 -344.87% 20.01%
2024
-243.64% 29.35%
Unlock
2025
-132.35% 45.68%
Unlock
2026
-61.18% 53.77%
Unlock

1 Analyst has issued a net profit forecast NeuroOne Medical Technologies Corp 2024 . The average NeuroOne Medical Technologies Corp net profit estimate is

$-10.5m
Unlock
. This is
21.23% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-10.5m 21.23%
Unlock
, the lowest is
$-10.5m 21.23%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-18.1m 3.17%
2024
$-10.5m 41.83%
Unlock
2025
$-7.9m 24.98%
Unlock
2026
$-4.7m 40.00%
Unlock

Net Margin

2023 -530.87% 35.86%
2024
-191.42% 63.94%
Unlock
2025
-77.41% 59.56%
Unlock
2026
-31.17% 59.73%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Sep '23 2024
Estimates
Earnings Per Share $ -0.65 -0.40
3.17% 38.46%
P/E negative
EV/Sales 5.03

1 Analysts have issued a NeuroOne Medical Technologies Corp forecast for earnings per share. The average NeuroOne Medical Technologies Corp <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-0.40
Unlock
. This is
16.67% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-0.40 16.67%
Unlock
, the lowest is
$-0.40 16.67%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-0.65 3.17%
2024
$-0.40 38.46%
Unlock
2025
$-0.30 25.00%
Unlock
2026
$-0.18 40.00%
Unlock

P/E ratio

Current -1.47 32.88%
2024
-2.73 85.71%
Unlock
2025
-3.63 32.97%
Unlock
2026
-6.06 66.94%
Unlock

Based on analysts' sales estimates for 2024, the NeuroOne Medical Technologies Corp stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 5.25 14.36%
2024
5.03 4.14%
Unlock
2025
2.71 46.08%
Unlock
2026
1.82 32.89%
Unlock

P/S ratio

Current 5.59 17.14%
2024
5.45 2.44%
Unlock
2025
2.94 46.08%
Unlock
2026
1.97 32.90%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today